HLA-G is the only major histocompatibility complex molecule expressed in the human placenta and thus has been considered to be necessary for maintenance of pregnancy. We investigated whether HLA-G expression is regulated in a parent-of-origin allele-specific manner. Of six first trimester and three third trimester placentas, three first trimester and two third trimester placentas showed heterozygosity at the PstI polymorphic site in the T-untranslated region. Reverse transcription-polymerase chain reaction (RT-PCR) analysis revealed biallelic expression of HLA-G in all the informative cases, indicating that HLA-G is not imprinted during the gestational period, at least at the transcriptional level. As HLA-G has been postulated to be polymorphic not only at the DNA sequence level but also at the peptide level, co-dominant expression of the gene suggests that each parental allele is involved in the allogenic response during pregnancy.
INTRODUCTION
It is of interest that human embryos and fetuses, semiallografts to the maternal immune system, are not rejected during pregnancy. This is in part explicable by the lack of expression of the classical class I major histocompatibility complex (MHC) molecules (HLA-A, -B, and -C) (Lata et al., 1990; Hunt and Orr, 1992) involved in graft rejection in placental trophoblasts. However, according to recent investigations, instead of classical class I HLAs, HLA-G (Geraghty et al., 1987) , a nonclassical class I MHC is expressed in the placenta (Ellis et al., 1990; Hunt and Orr, 1992; Chumbley et al., 1993) . Although the fundamental function of HLA-G remains unclear, it may regulate feto-maternal immunity in the tolerant condition during pregnancy since HLA-G is the only major histocompatibility antigen that is expressed in the human placenta. The importance of placental HLA-G is also suggested by its tissue distribution; it is expressed mainly in the placenta/fetal membranes and eyes (Shukla et al., 1990) , both of which are immunologically unique organs.
To explain the feto-maternal immunotolerance during pregnancy, one attractive hypothesis is that HLA-G expression is regulated in a parent-of-origin allele-specific manner, Le., by genomic imprinting. The state may be accomplished in the maternal body in which only one parental antigen of the fetus is exposed by repressing either parental allele. Although the mouse equivalent counterpart of HLA-G remains unidentified (Hunt, 1992) , an evidence has been presented that rat basal trophoblast expresses a non-classical class I MHC antigen (Pa), which is parentally imprinted (Kanbour-Shakir et al., 1990) . In fact, HLA-G has been suggested to be a candidate of an imprinted gene (Goshen et al., 1994) . In man, this gene maps to the short arm of chromosome 6 (Koller et aL, 1989) , a region syntenic to the proximal portion of mouse chromosome 17, where paternal imprinting effects, have been observed (Cattanach, 1991) . By analyzing cases of uniparental disomy, human chromosome 6 has been suggested to be subject to imprinting (Ledbetter and Engel, 1995) . Thus, whether HLA-G is an imprinted gene or not is a subject of interest. Although HLA-G is classified as a non-classical class I (class Ib) MHC molecule and was initially thought to be a monomorphic antigen, several DNA sequence polymorphisms within the peptide-coding regions have been reported recently (van der Ven and Ober, 1994; Watanabe et al., 1995) , suggesting that HLA-G is actually a polymorphic antigen. In the present study, we investigated the allele-specific expression of HLA-G by utilizing RT-PCR with polymerase chain reaction-restriction fragment length polymorphisms (PCR-RFLP) at the 3'-untranslated region to examine whether HLA-G is imprinted in the human placenta.
MATERIALS AND METHODS

Establishment of PCR-RFLP in exon 8 of HLA-G. PstI RFLP was
established on the basis of the reported single-nucleotide polymorphisms (Tamaki et al., 1993) . Genomic DNA (100 ng) from 54 unrelated Japanese individuals was amplified in 50/A PCR mixtures containing 10 mM Tris-HC1 (pH 8.3), 50 mM KCI, 1.5 mM MgC12, 0.01% gelatin, dNTPs (200,uM each (Fig. la) , and 1 unit of Taq DNA polymerase (Boehringer Mannheim GmbH Biochemica, Mannheim, Germany) in a thermal sequencer (Iwaki Glass, Co., Ltd., Chiba, Japan) under the following conditions: denaturation for 2 min at 94°C, then 35 cycles of 1 min at 94°C, 2 min at 57°C and 2 min at 72°C. The amplified fragments (847 bp) were digested with PstI (Toyobo, Co., Ltd., Tokyo, Japan), followed by 1% agarose gel electrophoresis. In alleles containing a PstI restriction site, digestion would yield 578 and 269 bp bands. Allele frequencies were as follows: allele A1 (without PstI restriction site), 0.31; allele A2 (containing PstI site), 0.69. The observed heterozygosity was 0.44.
Analysis of allele-specific expression by RT-PCR. After obtaining informed
consent, 6 first trimester placentas (6-10 weeks of gestation) and 3 third trimester placentas (39-40 weeks of gestation) were collected at therapeutic termination and at the time of delivery, respectively in addition to paternal and maternal peripheral blood samples. Genomic DNA was prepared from these samples by the standard protocol using proteinase K/SDS digestion and phenol/chloroform extraction and was amplified by PCR. From placentas showing DNA heterozygosity at the PstI RFLP site, total RNA was extracted using the acid guanidium-phenolchloroform method (Silbert and Chenchik, 1993) and RT-PCR was performed for analysis of allelic expression, cDNA was synthesized from 1/xg of total RNA, using 50 pmol of primer GPM-5 and 200 units of Moloney murine leukemia virus reverse transcriptase (BRL, Gaithersburg, MD) in a 20 ,ul reaction mixture for 1 hr at 37°C. The mixture was then heated for 10 min at 95°C to inactivate the reverse transcriptase. PCR and RFLP analysis were also performed similarly as described for genomic DNA. After restriction enzyme digestion, the expressed alleles were determined by comparing their parental genomic alleles (Fig. lb) , Southern blotting. To further confirm that the amplified products were specific to HLA-G, the internal oligonucleotide probe GOP-2 (5'-CACAGGGG-TGGGCTGGTCTC-Y) was synthesized to correspond to the specific site. The alkaline-blotted membrane was hybridized with the [a2p]-labeled probe at 50°C for 1 hr in hybridization solution (Stratagene, La Jolla, CA), washed in 2 × SSC containing 0.1% SDS, and exposed to Kodak XAR film (Eastern Kodak, Rochester, NY) overnight at --80°C (Fig. ic) .
RESULTS AND DISCUSSION
A total of 6 first trimester placentas and 3 third trimester placentas were examined for heterozygosity at the PstI RFLP site in exon 8. Among them, 3 first trimester placentas and 2 third trimester placentas were heterozygous at this site. Since class I HLAs contain highly homologous sequences, the internal otigonucleotide probe GOP-2 specific for HLA-G was used to further confirm the specificity of the products (Fig. la) . In contrast to our expectations, amplification of mRNAs by RT-PCR showed that both parental alleles were co-dominantly expressed in all the first and the third trimester placentas showing heterozygosity (two representative cases are shown in Fig. 1 ). These results indicated that (1) HLA-G is not subject to genomic imprinting at least at the transcriptional level and (2) the lack of imprinting in the placenta may be universal regardless of gestational weeks. Therefore, the possibility that imprinting is functionally established during the course of pregnancy as in human HI9 gene (Jinno et al., 1995) is unlikely. Also in equine trophoblasts, MHC class I molecules are biallelically coexpressed (Donaldson et aL, 1994) , thus, regulation of allelic expression of MHC molecules in the placenta may be specific to species, although further investigations on genomic imprinting in a wide-range of mammalian species are required before a conclusion can be made.
HLA-G may encode a wide variety of peptides that can act in the allogenic response since evidences suggesting the existence of HLA-G antigenic polymorphisms have been reported (van der Ven and Ober, 1994; Watanabe et al., 1995) . If so, our observation that HLA-G is expressed biallelically suggests an involvement of the MHC antigen derived from the paternal allele which is in contact with the maternal immune system in the maintenance of pregnancy. The paternal allele of HLA-G may play a major role in the development or differentiation of trophoblasts. This is further supported by the results of mouse pronuclear transfer experiments in which the paternal genome was shown to be essential for placental development (Barton et aL, 1984) . The expression of HLA-G is unique in the placenta in that its temporal and spatial expression patterns are altered during pregnancy. HLA-G expression is restricted to differentiated cytotrophoblasts (McMaster et aL, 1995) and its expression level in the placenta decreases with advance of pregnancy (Wei and Orr, 1990) , while strong expression was observed in the extravillous membrane at term (Wei and Orr, 1990) . The aberrant expression of HLA-G may be relevant to some prenatal complications that have been considered due to unexplained abnormal feto-maternal immunity. For instance, spontaneous abortion including habitual abortion or fetal growth retardation might be explained by the involvement of HLA-G. In other situations, HLA-G may play a defensive role in protecting the placenta from stressful conditions such as infections (Onno et al., 1994) . Thus, detection of paternal and maternal alleles of HLA-G at the DNA and mRNA levels by the PstI RFLP described here may be a useful tool for genetic analysis of these pathological conditions.
